StemCells, Inc. To Acquire Cell-Based Drug Discovery Platforms And Related Businesses Of Stem Cell Sciences plc
StemCells, Inc. and Stem Cell Sciences plc announced recently that they have entered into a definitive agreement pursuant to which StemCells will acquire the operating subsidiaries and certain related assets of Stem Cell Sciences (SCS) for 2,650,000 shares of StemCells common stock and approximately $715,000 in cash. Stem Cell Sciences is a UK-based company focused on commercializing …
[Read the full article here]Related News:
StemCells, Inc. to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc (Centre Daily Times)
StemCells, Inc. Closes Its Acquisition of the Operating Assets and Businesses of Stem Cell Sciences Plc
StemCells to Acquire Stem Cell Sciences for $4.8M (GenomeWeb News)